Position history for BlackRock, Inc.'s holdings in ATRIUM THERAPEUTICS INC
BlackRock, Inc. holds 1.2M shares of RNA (ATRIUM THERAPEUTICS INC), worth $16.1M as of 2026-Q1. This is a new position. RNA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$16.1M
Current Shares
1.2M
Total Value Change
$0
Total Shares Change
0
Other major holders of RNA: RA CAPITAL MANAGEMENT, L.P., Pentwater Capital Management LP, GOLDMAN SACHS GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC
New |
| 1.2M |
- |
| $16.1M |
| 0.0% |
| $15.67 |
39 |